investor login

contact

team

dedicated funds

news

 portfolio

Developing first-in-class approach to activate myeloid cells to kill cancer. 

VISIT WEBSITE

Active, Bio Tech, HOF I, HVP VI

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio